Tianjin Ringpu Bio-TechnologyLtd バランスシートの健全性
財務の健全性 基準チェック /56
Tianjin Ringpu Bio-TechnologyLtd has a total shareholder equity of CN¥5.0B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 25.7%. Its total assets and total liabilities are CN¥7.4B and CN¥2.5B respectively. Tianjin Ringpu Bio-TechnologyLtd's EBIT is CN¥417.8M making its interest coverage ratio 36.8. It has cash and short-term investments of CN¥1.7B.
主要情報
25.7%
負債資本比率
CN¥1.27b
負債
インタレスト・カバレッジ・レシオ | 36.8x |
現金 | CN¥1.69b |
エクイティ | CN¥4.96b |
負債合計 | CN¥2.48b |
総資産 | CN¥7.44b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Recent updates
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More
Oct 08Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 26Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet
Aug 23Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Apr 05Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity
Mar 28財務状況分析
短期負債: 300119's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.7B).
長期負債: 300119's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥736.6M).
デット・ツー・エクイティの歴史と分析
負債レベル: 300119 has more cash than its total debt.
負債の削減: 300119's debt to equity ratio has increased from 21% to 25.7% over the past 5 years.
債務返済能力: 300119's debt is well covered by operating cash flow (42.2%).
インタレストカバレッジ: 300119's interest payments on its debt are well covered by EBIT (36.8x coverage).